Here's why these 4 ASX shares are getting crushed today

The S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) might be rallying today but here are four shares that are getting crushed.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Following the US Federal Reserve's decision to keep US interest rates on hold and an overnight rally in commodity prices, the S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) is enjoying a solid day of gains with the main index rallying 1.2%.

Not all shares are taking part in today's rally, however, and these four companies are deep in the red:

ResMed Inc. (CHESS) (ASX: RMD)

ResMed shares have lost more than 4% today despite the absence of any specific company news being released. It appears investors may be concerned about the impact of the recent surge in the Australian dollar which will negatively impact the value of its ASX scrip. Investors may also be weary of further competition in the sector with the likes of Somnomed Limited (ASX: SOM) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) both delivering healthy growth in their most recent earnings results.

Magellan Financial Group Ltd (ASX: MFG)

Shares of Magellan are down by more than 2.2% today as investors digest the potential negative impact on its earnings from a higher Australian dollar. Despite this, Magellan still looks like a good long-term winner thanks to its superior track record of delivering out-performance and strong relationships with institutional investors.

Ramsay Health Care Limited (ASX:RHC)

The shares of the private hospital operator have been under pressure over the past seven trading days and today's 1% fall takes its seven-day loss to more than 8%. Ramsay is the market leader in France and it appears most of the recent share price decline can be attributed to the French Government's decision to cut its tariffs for private hospitals by more than anticipated. Despite this, the company has assured investors this would not impact the company's earnings guidance which was recently upgraded following the release of its first half earnings in February.

Retail Food Group Limited (ASX: RFG)

Shares of Retail Food Group started the day on the back foot and at one point had fallen more than 5.6%. The shares have since stabilised but were still trading down by more than 4.5% at the time of writing. The obvious reason for the fall is that the shares are trading ex-dividend today. The company will pay investors a fully-franked dividend of 13 cents a share – an increase of 13% from the previous corresponding period.

Motley Fool contributor Christopher Georges owns shares of Retail Food Group. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia owns shares of Retail Food Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »